ARTIFICIAL VITAL ORGANS AND MEDICAL BIONICS MARKET ANALYSIS

Regional Analysis

Global Artificial Vital Organs And Medical Bionics Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global artificial vital organs and medical bionics market over the forecast period. North America is estimated to hold 35.5% of the market share in 2023. The global artificial vital organs and medical bionics market is expected to witness significant growth in the coming years, driven by the high prevalence of cardiovascular disorder, favorable health reimbursement, and increased awareness. Increasing prevalence of neurological disorders is contributing to the growth of the artificial vital organs and medical bionics market in North America region. Primary factors contributing to the segment's growth are the increasing demand for cochlear implants, vision, exoskeleton, limbs, and brain bionics. Furthermore, fast-track U.S. Food and Drug Administration (FDA) approval for implants are strengthening the growth of the market for artificial organs and bionics. For instance, in January 2022, the Cochlear Nucleus Implants of Cochlear Limited received clearance from the U.S. Food and Drug Administration to treat unilateral hearing loss and single-sided deafness.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa